ID
25724
Beschrijving
Study ID: 101468/207 Clinical Study ID: SKF-101468/207 Study Title:A double-blind, randomized, placebo-controlled, parallel-group study to investigate the tolerability of a dose-escalating regimen of ropinirole in patients suffering from Restless Legs Syndrome (RLS). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication : Restless Legs Syndrome Concomitant Medication Section (Treatment Phase and Follow-Up)
Trefwoorden
Versies (1)
- 12-09-17 12-09-17 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
12 september 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC-ND 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Concomitant Medication Section GSK Ropinirole Restless Legs Syndrome 101468
Concomitant Medication Section GSK Ropinirole Restless Legs Syndrome 101468
Beschrijving
Concomitant Medication - If Medical History section is included indications on Prior Medication page must correlate utilizing the same terminlogy. Indication on concomitant page must be recorded on the Adverse Events Page and expressed utilizing the same terminology. If a medication was marked continuing at the initial visit (On the Prior and Concomitant Medication Page), but has since had a dosage change or has been stopped, it must be recorded on this form as a change with the start and end date.
Alias
- UMLS CUI-1
- C2347852
Beschrijving
If "YES", please record all medications used below. Where appropriate, medical conditions should be recorded on the Adverse Events Form, utilizing the same terminology. If a medication has had a dosage change it must be recorded with the start and stop date.
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C0443172
Beschrijving
Drug Name
Datatype
text
Alias
- UMLS CUI [1]
- C0013227
Beschrijving
Dose
Datatype
text
Alias
- UMLS CUI [1]
- C3174092
Beschrijving
Dose Frequency
Datatype
text
Alias
- UMLS CUI [1]
- C2826654
Beschrijving
Administration Route
Datatype
text
Beschrijving
Indication
Datatype
text
Alias
- UMLS CUI [1]
- C3146298
Beschrijving
Start Date - As a minimum the year must be started.
Datatype
date
Maateenheden
- dd-mmm-yyyy
Beschrijving
Start Time
Datatype
time
Maateenheden
- 24hr:min
Alias
- UMLS CUI [1]
- C1301880
Beschrijving
End Date
Datatype
date
Maateenheden
- dd-mmm-yyyy
Alias
- UMLS CUI [1]
- C0806020
Beschrijving
End Time
Datatype
time
Maateenheden
- 24hr:min
Alias
- UMLS CUI [1]
- C1522314
Beschrijving
Ongoing
Datatype
boolean
Alias
- UMLS CUI [1]
- C0549178
Similar models
Concomitant Medication Section GSK Ropinirole Restless Legs Syndrome 101468
C0019994 (UMLS CUI [1,2])
C0443172 (UMLS CUI [1,2])